For example, of the 26k samples across all cancers lacking common TP53 mutations, 2.2k (7.8%) show mutations in the Zinc-finger genes and positions mentioned above, thus potentially providing a molecular mechanism for tumor suppressor activities that might have been overlooked. The gene discussed is TP53; the disease is cancer.